The global single-use bioprocessing market size is expected to reach USD 33.0 billion by 2027, expanding at a CAGR of 12.8% over the forecast period, according to a new report by Grand View Research, Inc. Owing to the high demand for biopharmaceuticals, suppliers’ product portfolios of disposables have become more robust. Single-use bioprocessing equipment suppliers are working closely with customers to fulfill the growing expectations of customers. Furthermore, significant advancements in bioreactor designing, stirring systems, and film technologies have spurred the revenue in the market.
Increasing
demand for disposables consumables has led to several acquisitions, mergers,
and partnerships. For instance, Wego Pharmaceuticals is engaged in a
partnership with GE Healthcare for the manufacturing of disposables. Similarly,
Emergent BioSolutions is working in collaboration with ABEC for the
establishment of a Single-use System (SUS)-based dual plant in Maryland.
Intelligent
biomanufacturing holds great potential in further advancements of single-use
manufacturing. Thus, a substantial number of manufacturers are shifting towards
automating their workflows which involves the use of SUS. In addition, an
increase in the budget of biomanufacturers to incorporate new solutions within
their manufacturing plants is anticipated to boost the adoption rate in the
market.
Full Research Report On Single-use Bioprocessing Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/single-use-bioprocessing-market
Single-use
Bioprocessing Market Report Highlights
- Simple and peripheral
elements dominated the revenue share in 2019 owing to the high usage of
transfer systems and bags
- In addition, expanding
applications of disposable sensors in upstream biopharmaceutical
production has also driven the segment revenue
- Apparatus and plants are
expected to grow at a significant growth rate due to the increase in investment
in the disposable for downstream applications such as filtration and
purification
- Also, constant development
in Single-Use Bioreactors (SUBs) with respect to scale and working volume
is driving the segment
- Currently, the major
application of disposables is in upstream bioprocessing, leading to the
large revenue share of this segment
- The high usage rate of SUBs
coupled with the continuous introduction of novel products to accelerate
upstream processing is anticipated to spur revenue growth in this segment
- Biopharmaceutical
manufacturers are estimated as the largest key end-users of this
single-use bioprocessing market
- The continuous expansion of
single-use manufacturing facilities by contract manufacturing organizations
is one of the key drivers for the growth of biopharmaceutical
manufacturers
- North America captured the
largest revenue share in 2019 as a result of the presence of a substantial
number of key biopharmaceutical developers in the region
- Moreover, U.S. encompasses
the largest biopharmaceutical market, which has positively influenced the
uptake of disposables in this country
- Asia Pacific is expected to
be the fastest-growing market, with China and India at the forefront,
owing to the continuous expansion of biomanufacturing capabilities in the
region
- Domestic players are
collaborating with global players for the establishment of joint ventures
to drive biologics product in the region
- This is anticipated to
increase the use of SUS in Asia Pacific bioprocessing industry
- Key players including GE
Healthcare, Sartorius AG, Lonza, and Eppendorf AG dominate the market
- With the wide acceptance of
single-use bioprocessing products within the biopharmaceutical industry,
these companies continue to supplant their conventional bioprocessing
product line with new disposable products
Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/single-use-bioprocessing-market/request/rs1
Single-use
Bioprocessing Market Segmentation
Grand View Research has segmented
the global single-use bioprocessing market on the basis of product, workflow,
end use, and region:
Single-use
Bioprocessing Product Outlook (Revenue, USD Million, 2016 - 2027)
- Simple & Peripheral
Elements
- Tubing, Filters,
Connectors, & Transfer Systems
- Bags
- Sampling Systems
- Probe & Sensors
- pH Sensor
- Oxygen Sensors
- Pressure Sensors
- Temperature Sensors
- Conductivity Sensors
- Flow Sensors
- Other Sensors
- Others
- Apparatus & Plants
- Bioreactors
- Bioreactors, By Capacity
- Upto 1000 L
- Above 1000 to 2000 L
- Above 2000 L
- Mixing, Storage, &
Filling Systems
- Filtration system
- Chromatography Systems
- Others
- Work Equipment
- Cell Culture System
- Syringes
- Others
Single-use
Bioprocessing Workflow Outlook (Revenue, USD Million, 2016 - 2027)
- Upstream
- Fermentation
- Downstream
Single-use
Bioprocessing End-use Outlook (Revenue, USD Million, 2016 - 2027)
- Biopharmaceutical
Manufacturer
- CMOs & CROs
- In-house Manufacturer
- OEM
- Academic & Clinical
Research Institutes
- Others
Single-use
Bioprocessing Regional Outlook (Revenue, USD Million, 2016 - 2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Latin America
- Brazil
- Middle East & Africa
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment